alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Van Kaer L (2005) Nat Rev Immunol 5: 31-42 Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, Griffin MR, Herrinton LJ, Liu L, Ouellet-Hellstrom R, Patkar NM, Solomon DH, Lewis JD, Xie F, Saag KG, Curtis JR (2011) JAMA 306: 2331-9 Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10. Engler DB, Reuter S, van Wijck Y, Urban S, Kyburz A, Maxeiner J, Martin H, Yogev N, Waisman A, Gerhard M, Cover TL, Taube C, Müller A (2014) Proc Natl Acad Sci U S A 111: 11810-5 Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Leonard JP, Sherman ML, Fisher GL, Buchanan LJ, Larsen G, Atkins MB, Sosman JA, Dutcher JP, Vogelzang NJ, Ryan JL (1997) Blood 90: 2541-8 Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion. Houot R, Goldstein MJ, Kohrt HE, Myklebust JH, Alizadeh AA, Lin JT, Irish JM, Torchia JA, Kolstad A, Chen L, Levy R (2009) Blood 114: 3431-8 Imatinib: novel treatment of immune-mediated kidney injury. Wallace E, Gewin L (2013) J Am Soc Nephrol 24: 694-701 Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model. Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, Hailemichael Y, Fokt I, Jayakumar A, Qiao W, Fuller GN, Overwijk WW, Priebe W, Heimberger AB (2010) Clin Cancer Res 16: 2550-61 Combining Biologics in Inflammatory Bowel Disease and Other Immune Mediated Inflammatory Disorders. Hirten RP, Iacucci M, Shah S, Ghosh S, Colombel JF (2018) Clin Gastroenterol Hepatol 16: 1374-1384 Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza. Karlström A, Heston SM, Boyd KL, Tuomanen EI, McCullers JA (2011) J Infect Dis 204: 1358-66 Helicobacter pylori and its secreted immunomodulator VacA protect against anaphylaxis in experimental models of food allergy. Kyburz A, Urban S, Altobelli A, Floess S, Huehn J, Cover TL, Müller A (2017) Clin Exp Allergy 47: 1331-1341 Members of the salivary gland surface protein (SGS) family are major immunogenic components of mosquito saliva. King JG, Vernick KD, Hillyer JF (2011) J Biol Chem 286: 40824-34 Combinatorial approach to cancer immunotherapy: strength in numbers. Vilgelm AE, Johnson DB, Richmond A (2016) J Leukoc Biol 100: 275-90 Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression. Patil NK, Bohannon JK, Sherwood ER (2016) Pharmacol Res 111: 688-702 Melacine: an allogeneic melanoma tumor cell lysate vaccine. Sosman JA, Sondak VK (2003) Expert Rev Vaccines 2: 353-68 Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population. Grijalva CG, Chung CP, Stein CM, Mitchel EF, Griffin MR (2008) Rheumatology (Oxford) 47: 1061-4 Intrapulmonary administration of leukotriene B4 enhances pulmonary host defense against pneumococcal pneumonia. Mancuso P, Lewis C, Serezani CH, Goel D, Peters-Golden M (2010) Infect Immun 78: 2264-71 Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A. Luan L, Patil NK, Guo Y, Hernandez A, Bohannon JK, Fensterheim BA, Wang J, Xu Y, Enkhbaatar P, Stark R, Sherwood ER (2017) Sci Rep 7: 40050 Increased serum tumor necrosis factor α levels in patients with lenalidomide-induced hypothyroidism. Iams WT, Hames ML, Tsai JP, Dahlman KB, Talbott MS, Richards KL, Reddy NM (2015) Exp Hematol 43: 74-8 Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics? Toh S, Li L, Harrold LR, Bayliss EA, Curtis JR, Liu L, Chen L, Grijalva CG, Herrinton LJ (2012) Pharmacoepidemiol Drug Saf 21: 524-34 An odyssey into biologic therapy. Wujcik D (1993) Oncol Nurs Forum 20: 879-87 Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major. Hussein AA, Al-Zaben A, Ghatasheh L, Natsheh A, Hammada T, Abdel-Rahman F, Abu-Jazar H, Sharma S, Najjar R, Frangoul H (2013) Pediatr Blood Cancer 60: 1345-9 Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies. Pawate S, Wang L, Song Y, Sriram S (2012) J Neuroimaging 22: 137-44
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.